Dr Gordon James Carroll, PHARM D in Carbondale, KS - Pharmacist

Dr Gordon James Carroll, PHARM D is a Pharmacist based in Carbondale, Kansas. Dr Gordon James Carroll is licensed to practice in Kansas (license number 1-15969) and his current practice location is 211 Main St, Carbondale, Kansas. He can be reached at his office (for appointments etc.) via phone at (785) 836-7202.

NPI number for Dr Gordon James Carroll is 1114329968 and his current mailing address is 211 Main St, Carbondale, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1114329968.

Contact Information

	Dr Gordon James Carroll, PHARM D
	211 Main St, Carbondale, KS 66414-9714
	(785) 836-7202
	(785) 836-7208

Healthcare Provider's Profile

Full Name	Dr Gordon James Carroll
Gender	Male
Speciality	Pharmacist
Location	211 Main St, Carbondale, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1114329968
Provider Enumeration Date: 09/24/2014
Last Update Date: 09/24/2014

Medical Identifiers

Medical identifiers for Dr Gordon James Carroll such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114329968	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-15969 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gordon James Carroll is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gordon James Carroll, PHARM D 211 Main St, Carbondale, KS 66414-9714 Ph: (785) 836-7202	Dr Gordon James Carroll, PHARM D 211 Main St, Carbondale, KS 66414-9714 Ph: (785) 836-7202

News Archive

Researchers to begin drug development projects for rare and neglected diseases

Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease.

NIH to fund grants for epigenetic research

The National Institutes of Health announced today that it will fund 22 grants on genome-wide studies of how epigenetic changes - chemical modifications to genes that result from diet, aging, stress, or environmental exposures - define and contribute to specific human diseases and biological processes.

Anti-clotting action of clopidogrel (Plavix) reduced by common heartburn drugs

The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.

Dr Gordon James Carroll, PHARM D - Pharmacist in Carbondale, KS